with levels increasing after discontinuing sargramostim a GM-CSF = granulocyte-macrophage colony-stimulating factor; BCG = bacillus Calmette-Guérin vaccine; RR = response rate, including complete ...
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
The four colony-stimulating factors (CSFs) are glycoproteins that ... Recombinant granulocyte-CSF (G-CSF) and granulocyte–macrophage-CSF (GM-CSF) have now been used to increase dangerously ...
Hosted on MSN11mon
Japan’s PMDA approves Partner’s inhaled Leukine for aPAPThis is the first regulatory approval of an inhaled recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) product for this indication. In Japan, Leukine is branded as Sargmalin and ...
Y-mAbs Therapeutics (YMAB) announced the publication of interim data from a Phase 2 clinical trial evaluating naxitamab with ...
Hosted on MSN1mon
Molgramostim shows promise in rare lung disease treatmentMolgramostim, a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), is designed to stimulate alveolar macrophages to clear surfactant effectively. Savara's forward-looking ...
In addition to their cytoprotective role in stressful conditions, heat shock proteins (HSPs) are involved in specific differentiation pathways, for example, we have identified a role for HSP90 in ...
with levels increasing after discontinuing sargramostim a GM-CSF = granulocyte-macrophage colony-stimulating factor; BCG = bacillus Calmette-Guérin vaccine; RR = response rate, including complete ...
Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback